# ## ## ## ||Page| |---|---| |**Reference and Administrative Details of the Company, its Trustees and Advisers**|**1**| |**Trustees' Report**|2 −4| |**Independent Examiner's Report**|5| |**Statement of Financial Activities**|6| |**Balance Sheet**|7| |**Notes to the Financial Statements**|**8 −18**| ## ## |**Trustees**|Charles Pike, Chair| |---|---| ||Ben Wilson| ||Joseph Mclean| |**Company registered**|| |**number**|07802097| |**Charity registered**|| |**number**|1145808| |**Registered office**|31 Hill Street| ||London| ||W1J5LS| |**Accountants**|Williams Giles Professional Services Ltd| ||Sittingbourne| ||Kent| ||ME10 5BH| |**Bankers**|**Coutts &**Co| ||440 Strand| ||London| ||WC2R OQS| |**Solicitors**|Fosters LLP| ||31 Hill Street| ||London| ||W1J 5LS| ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## |||**Unrestricted**|**Restricted**|**Total**|_Total_| |---|---|---|---|---|---| |||**funds**|**funds**|**funds**|_funds_| |||**2022**|**2022**|**2022**|_2021_| ||**Note**|**£**|**£**|**£**|r| |**Income from:**|||||| |Donations and legacies|3|**6,971**|**56,112**|**63,083**|_161,409_| |Other income|4|**1,930**||**1,930**|_6,278_| |**Total income**||**8,901**|**56,112**|**65,013**|/67,687| |**Expenditure on:**|||||| |Charitable activities|6|**2,604**|**28,905**|**31,509**|_183,021_| |**Total expenditure**||**2,604**|**28,905**|**31,509**|_183,021_| |**Net income/(expenditure)**||**6,297**|**27,207**|**33,504**|_(15,334)_| |Transfers between funds|12|**(6,660)**|**6,660**||| |**Net movement in funds**||**(363)**|**33,867**|**33,504**|_(15,334)_| |**Reconciliation of funds:**|||||| |Total funds brought forward||**(2,743)**|**34,174**|**31,431**|_46,765_| |Net movement in funds||**(363)**|**33,867**|**33,504**|_(15,334)_| |**Total funds carried forward**||**(3,106)**|**68,041**|**64,935**|_31,431_| ## ## ||||**2022**||_2021_| |---|---|---|---|---|---| ||**Note**||**E**||| |**Current assets**|||||| |Cash at bank and in hand||**69,189**||_35,381_|| |||**69,189**||_35,381_|| |Creditors: amounts falling due within one|||||| |year|10|**(4,254)**||_(3,950)_|| |**Net current assets**|||**64,935**||_31,431_| |**Total net assets**|||**64,935**||_31,431_| |**Charity funds**|||||| |Restricted funds|12||**68,041**||_34,174_| |Unrestricted funds|12||**(3,106)**||_(2,743)_| |**Total funds**|||**64,935**||_31,431_| ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## |||**Unrestricted**|**Restricted**|**Total**|_Total_| |---|---|---|---|---|---| |||**funds**|**funds**|**funds**|_funds_| |||**2022**|**2022**|**2022**|_2021_| |||**£**|**£**|**£**|_£_| ||Donations|5,846|56,062|**61,908**|_140,345_| ||Grants||||_2,000_| ||Similar incoming resources|1,125|50|**1,175**|_19,064_| ||**Total 2022**|6,971|56,112|**63,083**|_161,409_| ||_Total 2021_||161,409|161,409|| |**4.**|**Other incoming resources**||||| ||||**Unrestricted**|**Total**|_Total_| ||||**funds**|**funds**|_funds_| ||||**2022**|**2022**|_2021_| ||||**£**|**£**|_£_| ||Other incoming resources||1,930|**1,930**|_6,278_| ||_Total 2021_||_6,278_|_6,278_|| |**5.**|**Analysis−of grants**||||| ||||**Grants to**|**Total**|_Total_| ||||**Institutions**|**funds**|_funds_| ||||**2022**|**2022**|_2021_| ||||**£**|**£**|_£_| ||Grants, Developing and supporting charitable projects||28,905|**28,905**|_175,787_| ||_Total 2021_||_175,787_|_175,787_|| ## ## ## |The Company has made the following material grants to ins|titutions during the year:|| |---|---|---| ||**2022**|_2021_| |**Name of institution**||| |The Bergen Philharmonic Orchestra|**4,500**|| |Sporting Partnerships Foundation|**6,678**|| |Alex Wardle Foundation|**2,867**|| |Opera Ventures|**7,100**|_2,484_| |Berahino Funds||_10,000_| |Breast Cancer||_6,000_| |Rugby Against Cancer||_6,225_| |Sinfonia of London|**7,760**|_151,078_| ||**28,905**|/75,787| ## ## ||**Unrestricted**|**Restricted**||| |---|---|---|---|---| ||**funds**|**funds**|**Total**|_Total_| ||**2022**|**2022**|**2022**|_2021_| ||**£**|**£**|**£**|£| |Grant making to institutions||28,905|**28,905**|175,787| |Support
−costs|2,604||**2,604**|_7,234_| |**Total 2022**|2,604|28,905|**31,509**|_183,021_| |_Total 2021_|_(1,609)_|_184,630_|_183,021_|| ## ## ## ||||**Grant**|||| |---|---|---|---|---|---|---| ||||**funding of**|**Support**|**Total**|_Total_| ||||**activities**|**costs**|**funds**|_funds_| ||||**2022**|**2022**|**2022**|_2021_| ||||**£**|**£**|**£**|_r_| ||Developing and supporting charitable projects||28,905||**28,905**|175,787| ||Support costs|||2,604|**2,604**|_7,234_| ||**Total 2022**||28,905|2,604|**31,509**|_183,021_| ||_Total 2021_||_175,787_|_7,234_|_183,021_|| ||**Analysis of support costs**|||||| |||||**Developing**||| |||||**and**||| |||||**supporting**||| |||||**charitable**|**Total**|_Total_| |||||**projects**|**funds**|_funds_| |||||**2022**|**2022**|_2021_| ||Advertising and website development|||||_200_| ||Travel and subsistence costs|||||528| ||Other costs|||||_(1,072)_| ||Transaction fees|||||_5,778_| ||Governance costs|_||2,604|**2,604**|_1,800_| |||||2,604|**2,604**|_7,234_| ||_Total 2021_|||_7,234_|_7,234_|| |**8.**|**Independent examiner's remuneration**|||||| ||||||**2022**|_2021_| ||Fees payable to the|Company's independent examiner for the||independent||| ||examination of the Company's annual accounts||||**1,020**|_600_| ||Fees payable to the|Company's independent examiner in respect of:||||| ||All other services not included above||||**1,584**|_1,200_| # ## ## ## ## ## ||**2022**|_2021_| |---|---|---| ||**£**|_£_| |Trade creditors|**1,650**|_2,150_| |Accruals and deferred income|**2,604**|_1,800_| ||**4,254**|_3,950_| ## |||**2022**|_2021_| |---|---|---|---| |||**£**|r| |**Financial **|**assets**||| |Financial|assets measured at fair value through income and expenditure|**69,189**|_35,381_| ## ## ## ||**Balance at 1**||||**Balance at**| |---|---|---|---|---|---| ||**November**|||**Transfers**|**31 October**| ||**2021**|**Income**|**Expenditure**|**in/out**|**2022**| ||**£**|**£**|**£**|**£**|**£**| |**Unrestricted funds**|||||| |General Funds|**(2,743)**|**8,901**|**(2,604)**|**(6,660)**|**(3,106)**| |**Restricted funds**|||||| |Restricted Fund|||||| ||−||||| |New Venture Opera Fund|||||| |Torbay Culture Development|||||| |Fund|**115**||**−**||**115**| |The Health Anxiety Fund|**1,123**||||**1,123**| |The Saido Berahino Fund|**4,480**||**−**|**(89)**|**4,391**| |Sporting Partnerships|||||| |Foundation Fund|**5,544**|**1,498**|**(6,678)**|**898**|**1,262**| |The Alex Wardle Foundation|||||| |Fund|**6,362**|**6,439**|**(2,867)**||**9,934**| |The Bergen Philharmonic|||||| |Orchestra Fund|**16,550**||**(4,500)**|**(241)**|**11,809**| |The Rugby Against Cancer|||||| |Fund|||||| ||−||−||| |Sinfonia of London Fund||**41,075**|**(7,760)**|**6,092**|**39,407**| |The New Opera Venture Fund||**7,100**|**(7,100)**||| ||**34,174**|**56,112**|**(28,905)**|**6,660**|**68,041**| |**Total of funds**|**31,431**|**65,013**|**(31,509)**||**64,935**| ## ## ## ||_Balance at_||||_Balance at_| |---|---|---|---|---|---| ||_1 November_|||_Transfers_|_31 October_| ||_2020_|_Income_|_Expenditure_|_in/out_|_2021_| ||_£_|_£_|_£_|_£_|_£_| |**Unrestricted funds**|||||| |General Funds|_(19,859)_|_6,278_|_1,609_|_9,229_|_(2,743)_| |**Restricted funds**|||||| |Restricted Fund|_9,229_|_51_|_(51)_|_(9,229)_|| |New Venture Opera Fund|_2,500_|_9_|_(2,509)_||| |Torbay Culture Development|||||| |Fund|_105_|_10_||_−_|_115_| |The Health Anxiety Fund||_1,267_|_(144)_||_1,123_| |The Saido Berahino Fund|_14,775_||_(10,295)_||_4,480_| |Sporting Partnerships|||||| |Foundation Fund|_5,657_||_(113)_||_5,544_| |The Alex Wardle Foundation|||||| |Fund|_4,970_|_4,322_|_(2,930)_|_−_|_6,362_| |The Bergen Philharmonic|||||| |Orchestra Fund|_16,888_||_(338)_||_16,550_| |The Rugby Against Cancer|||||| |Fund|_12,500_|_−_|_(12,500)_||| |Sinfonia of London Fund|−|_155,750_|_(155,750)_|_−_|| |The New Opera Venture Fund|||||| ||_66,624_|_161,409_|_(184,630)_|_(9,229)_|_34,174_| |**Total of funds**|_46,765_|_167,687_|_(183,021)_||_31,431_| ## ## ## ||**Balance at 1**||||**Balance at**| |---|---|---|---|---|---| ||**November**|||**Transfers**|**31 October**| ||**2021**|**Income**|**Expenditure**|**in/out**|**2022**| ||**£**|**£**|**£**|**£**|**£**| |General funds|**(2,743)**|**8,901**|**(2,604)**|**(6,660)**|**(3,106)**| |Restricted funds|**34,174**|**56,112**|**(28,905)**|**6,660**|**68,041**| ||**31,431**|**65,013**|**(31,509)**||**64,935**| |**Summary of funds −prior year**|||||| ||_Balance at_||||_Balance at_| ||_1 November_|||_Transfers_|_31 October_| ||_2020_|_Income_|_Expenditure_|_in/out_|_2021_| ||_r_|_r_|_r_|_r_|_r_| |General funds|_(19,859)_|_6,278_|_1,609_|_9,229_|_(2,743)_| |Restricted funds|_66,624_|_161,409_|_(184,630)_|_(9,229)_|_34,174_| ||_46,765_|_167,687_|_(183,021)_||_31,431_| ## ## ## |**Analysis of net assets between funds −current year**|||| |---|---|---|---| ||**Unrestricted**|**Restricted**|**Total**| ||**funds**|**funds**|**funds**| ||**2022**|**2022**|**2022**| ||**E**|**E**|**E**| |Current assets|(3,106)|72,295|**69,189**| |Creditors due within one year||(4,254)|**(4,254)**| |**Total**|(3,106)|68,041|**64,935**| |**Analysis of net assets between funds −prior year**|||| ||_Unrestricted_|_Restricted_|_Total_| ||_funds_|_funds_|_funds_| ||_2021_|_2021_|_2021_| |Current assets|_1,207_|_34,174_|_35,381_| |Creditors due within one year|_(3,950)_||_(3,950)_| |**Total**|_(2,743)_|_34,174_|_31,431_| ##